Meloxicam Mcc

Meloxicam, the active ingredient in Meloxicam Mcc, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a rectal formulation for rectal use. It reduces inflammation and pain associated with osteoarthritis, rheumatoid arthritis and acute musculoskeletal conditions in adult patients, and is used in the management of chronic joint disorders.

GNH USA supplies Meloxicam Mcc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured in the European Union under strict GMP standards, ensuring consistent quality for export to regulated markets.

Meloxicam acts on inflammatory pathways by selectively inhibiting COX‑2, thereby reducing prostaglandin synthesis and relieving pain and swelling in several musculoskeletal conditions.

- Osteoarthritis: improves joint mobility, reduces chronic pain, decreases stiffness, and enhances overall functional capacity in patients with degenerative joint disease. - Rheumatoid arthritis: diminishes synovial inflammation, reduces joint tenderness and swelling, helps preserve functional ability, and may slow progression of joint damage in rheumatoid arthritis. - Acute pain and inflammation: provides rapid relief of pain, edema, and erythema in short‑term inflammatory episodes such as sprains, strains, or post‑operative discomfort, improving patient comfort and facilitating early mobilization.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Mild skin rash

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Cardiovascular events such as myocardial infarction or stroke - Severe liver injury

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding before initiating therapy. Monitor renal function: check serum creatinine and eGFR periodically, especially in patients with pre‑existing kidney disease. Evaluate cardiovascular history: use caution in patients with hypertension, heart failure or prior thrombotic events. Use lowest effective dose: prescribe the minimum dose needed for symptom control and limit duration when possible. Avoid in known hypersensitivity: discontinue if allergic reactions such as rash or angioedema occur. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: potential for decreased renal perfusion and electrolyte imbalance.